OLANZAPINE FOR INJECTION DIN 02568578
Status: Approved
Holder: HIKMA CANADA LIMITED
Health Canada record
| Active ingredient(s) | OLANZAPINE (OLANZAPINE TARTRATE) 10 MG |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | N05AH03 OLANZAPINE |
|---|
| Original market date | |
|---|
| Current status date | 29-May-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Hikma Canada Limited — licence 3-002579, currently licensed, last inspection rating C (2022-04-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OLANZAPINE (OLANZAPINE TARTRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02247099 | ZYPREXA INTRAMUSCULAR | CHEPLAPHARM REGISTRATION GMBH | Powder For Solution | OLANZAPINE (OLANZAPINE TARTRATE) 10 MG | Marketed |
| 02416522 | OLANZAPINE FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | OLANZAPINE (OLANZAPINE TARTRATE) 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 37640 | 2026-05-29 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for OLANZAPINE FOR INJECTION
How to read a Canadian DIN record